News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.
|Title||High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.|
|Publication Type||Journal Article|
|Year of Publication||2011|
|Authors||Henderson CF, Brodsky RA, Jones RJ, Levine SM|
|Journal||Seminars in arthritis and rheumatism|
|Date Published||2011 Oct|
Behcet's disease (BD) is a systemic inflammatory disorder characterized by recurrent mucocutaneous ulcerations, ocular inflammation, and numerous severe systemic inflammatory manifestations. While most patients respond to standard immunosuppressive therapies, a subset will develop refractory disease. In this report, the use of a novel therapy for the treatment of BD is described.
|Alternate Journal||Semin. Arthritis Rheum.|